Clinical Trial of SEEG for Drug-resistant Epilepsy
NCT07923058, Not applicable, Not yet recruiting, Beijing Pins Medical Co., Ltd
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Clinical Trial of SEEG for Drug-resistant Epilepsy | ClinicalTrials.gov |
| NCT number | NCT07923058 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 99 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Beijing Pins Medical Co., Ltd | ClinicalTrials.gov |
| Conditions | Drug-Resistant Epilepsy | ClinicalTrials.gov |
| Interventions | SEEG RF-TC | ClinicalTrials.gov |
| First posted | 2026-11-06 | ClinicalTrials.gov |
| Last updated | 2026-11-06 | ClinicalTrials.gov |
Registered outcomes 16
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | SEEG Recording Success Rate | Within 30 days after implantation of electrodes | The proportion of patients achieving successful SEEG recording | ClinicalTrials.gov |
| Primary | RF-TC Efficacy Rate | Within 3 days after RF-TC | The proportion of patients achieving successful RF-TC.RF lesion measured on the post-procedural brain MRI. | ClinicalTrials.gov |
| Secondary | Electrode Placement Accuracy | Within 30 days after implantation of electrodes | co-registering the pre-operative surgical plan and post-op CT，calculate the error between the actual placement position of the electrode and the surgical plan at the skull entry point and the target point.Measuring unit: mm. | ClinicalTrials.gov |
| Secondary | Technical success rate of RF-TC | During RF-TC operation | Medical recording | ClinicalTrials.gov |
| Secondary | Vital signs-body temperature | baseline, Perioperative | From medical recording | ClinicalTrials.gov |
| Secondary | Vital signs-pulse | baseline, Perioperative | From medical recording | ClinicalTrials.gov |
| Secondary | Vital signs-respiratory rate | baseline, Perioperative | From medical recording | ClinicalTrials.gov |
| Secondary | Vital signs-blood pressure | baseline, Perioperative | From medical recording | ClinicalTrials.gov |
| Secondary | the reduction rate of spike frequency after RF-TC | Periprocedural of RF-TC | SEEG recording | ClinicalTrials.gov |
| Secondary | Questionnaire of Device Performance Evaluation | immediately after the procedure/surgery | a 5-level scale used to evaluate the Device Performance | ClinicalTrials.gov |
| Secondary | Seizure reduction rate | 90±7 days after RF-TC | Follow up | ClinicalTrials.gov |
| Secondary | Mini-Mental State Examination (MMSE) score | Before and 90±7 days after RF-TC | Lower score indicates worse cognitive impairment | ClinicalTrials.gov |
| Secondary | Quality of life in epilepsy-31 inventory (QOLIE-31) score | Before and 90±7 days after RF-TC | For adult; Higher scores correspond to better health-related quality of life | ClinicalTrials.gov |
| Secondary | Quality of life in epilepsy for Adolescents (QOLIE-AD-48) score | Before and 90±7 days after RF-TC | For Adolescents; Higher scores correspond to better health-related quality of life | ClinicalTrials.gov |
| Secondary | child epilepsy questionnnaire-parental form | Before and 90±7 days after RF-TC | For children; Higher scores correspond to better health-related quality of life | ClinicalTrials.gov |
| Other | Incidence of adverse events and serious adverse events | through study completion, an average of 5 months | Medical recording | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)